Edinburgh Cancer Research

Asier Unciti-Broceta

Innovative Therapeutics

Asier Unciti-Broceta
Asier Unciti-Broceta - Personal Chair of Medicinal Chemistry

Research in a Nutshell 

The Innovative Therapeutics Lab is led by Professor Asier Unciti-Broceta and based at Edinburgh Cancer Research, part of the Institute of Genetics and Cancer at the University of Edinburgh, where Asier established the first chemistry lab of the Institute in 2010. The lab explores novel chemical strategies to improve the efficacy and safety of cancer treatments. This includes development of highly-selective inhibitors of kinases involved in cancer and novel prodrug strategies aimed at improving the clinical use of well-established chemotherapy drugs.

 

Research Programme

Asier Unciti-Broceta group

People

 

Asier Unciti-Broceta

Professor of Medicinal Chemistry and Head of the Innovative Therapeutics Lab

Catherine Adam Chemistry Lab Manager
Alvaro Lorente-Macías Lead Synthetic Chemist
Yang Ge EPSRC Postdoctoral Fellow
Athina Polykandritou MRC Postdoctoral Fellow
Davir González EPSRC Postdoctoral Fellow
Bobby Kaghazchi Nuvectis Postdoctoral Fellow
Ben King PhD student
Iñigo Lanzagorta Calvillo PhD student
Jonathon Mock PhD student
Ross Milnes PhD student
Adam Smith PhD student
Ben Jones Visiting PhD student
John Hajek 5th year MChem student 

Contact

asier.ub@ed.ac.uk

Collaborations

  • Professor Neil Carragher (ECRC)

  • Dr Liz Patton (ECRC)

  • Professor Val Brunton (ECRC)
  • Professor Margaret Frame (ECRC)
  • Professor H. Leung (Beatson Institute / University of Glasgow)
  • Dr P. Brennan (Centre for Clinical Brain Sciences / University of Edinburgh)
  • Dr D. Sieger (Centre for Neuroregeneration / University of Edinburgh)
  • Dr C. Torres-Sánchez (Loughborough University)
  • Dr R. Sanchez-Martín and Dr J. J. Díaz-Mochón (GENyO / Spain)
  • Professor I. Molina (University of Granada / Spain)  

Scientific Themes

Anticancer Therapy, Kinase Inhibitors, Bioorthogonal Prodrugs, Palladium Implants, Nanotechnology

Technology Expertise

Small Molecule Synthesis and Peptides, Medicinal Chemistry, Design and Development of Prodrugs, Target ID and Imaging Tools, Heterogeneous Catalysts